Bone scan index: a quantitative treatment response biomarker for castration-resistant metastatic prostate cancer
Josef Fox
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012
View PDFchevron_right
Automated Bone Scan Index as a quantitative imaging biomarker in metastatic castration-resistant prostate cancer patients being treated with enzalutamide
liza angkat
View PDFchevron_right
Bone Scan Index and Progression-free Survival Data for Progressive Metastatic Castration-resistant Prostate Cancer Patients Who Received ODM-201 in the ARADES Multicentre Study
John Aspegren
European Urology Focus, 2016
View PDFchevron_right
Analytical Validation of the Automated Bone Scan Index as an Imaging Biomarker to Standardize the Quantitative Changes in Bone Scans of Patients with Metastatic Prostate Cancer
Reza Kaboteh
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015
View PDFchevron_right
A new parameter for measuring metastatic bone involvement by prostate cancer: the Bone Scan Index
Steven Larson
Clinical cancer research : an official journal of the American Association for Cancer Research, 1998
View PDFchevron_right
Role of bone scan index in the prognosis and effects of therapy on prostate cancer with bone metastasis: Study design and rationale for the multicenter Prostatic Cancer Registry of Standard Hormonal and Chemotherapy Using Bone Scan Index (PROSTAT-BSI) study
Kenichi Nakajima
International journal of urology : official journal of the Japanese Urological Association, 2018
View PDFchevron_right
Validation of a bone scan positivity risk table in non-metastatic castration-resistant prostate cancer
Daniel Moreira
BJU international, 2016
View PDFchevron_right
Automated bone scan index as predictors of survival in prostate cancer
Budi Darmawan,SE
World Journal of Nuclear Medicine, 2017
View PDFchevron_right
Evaluation of usage of bone scan index in assessment of metastatic prostate cancer
Adel Brčaninović
2021
View PDFchevron_right
A prospective study to evaluate the intra-individual reproducibility of bone scans for quantitative assessment in patients with metastatic prostate cancer
Reza Kaboteh
BMC medical imaging, 2018
View PDFchevron_right
Bone scan positivity in non-metastatic, castrate-resistant prostate cancer: external validation study
ashley johnston
International braz j urol, 2020
View PDFchevron_right
Predicting bone scan positivity in non-metastatic castration-resistant prostate cancer
Daniel Moreira
Prostate Cancer and Prostatic Diseases, 2015
View PDFchevron_right
The Automated Bone Scan Index as a Predictor of Response to Prostate Radiotherapy in Men with Newly Diagnosed Metastatic Prostate Cancer: An Exploratory Analysis of STAMPEDE’s “M1|RT Comparison”
Noel Clarke
European Urology Oncology, 2020
View PDFchevron_right
Progression of bone metastases in patients with prostate cancer - automated detection of new lesions and calculation of bone scan index
Reza Kaboteh, Milan Lomsky
EJNMMI research, 2013
View PDFchevron_right
Bone-related Parameters are the Main Prognostic Factors for Overall Survival in Men with Bone Metastases from Castration-resistant Prostate Cancer
Neal Shore, Lawrence Karsh
European urology, 2014
View PDFchevron_right
Scintigraphic load of bone disease evaluated by DASciS software as a survival predictor in metastatic castration-resistant prostate cancer patients candidates to 223RaCl treatment
MARIA IPPOLITI
Radiology and Oncology
View PDFchevron_right
Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: Results from SWOG S0421
David Quinn
Cancer Treatment and Research Communications, 2018
View PDFchevron_right
Bone Scan Index: a prognostic imaging biomarker for high-risk prostate cancer patients receiving primary hormonal therapy
Reza Kaboteh, Jan-erik Damber, Milan Lomsky
EJNMMI research, 2013
View PDFchevron_right
The value of bone scans to predict survival time in patients with diagnosed prostate cancer: single-center retrospective study
Doğangün Yüksel
Journal of Radiology and Oncology
View PDFchevron_right
A Novel Automated Platform for Quantifying the Extent of Skeletal Tumour Involvement in Prostate Cancer Patients Using the Bone Scan Index
Hans Lilja
2012
View PDFchevron_right
Do all patients with newly diagnosed prostate cancer need staging radionuclide bone scan? a retrospective study
Rami Alazab
International braz j urol, 2010
View PDFchevron_right
Application of bone scans for prostate cancer staging: Which guideline shows better result?
Ari chong
Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 2014
View PDFchevron_right
Association of Bone Metastatic Burden With Survival Benefit From Prostate Radiotherapy in Patients With Newly Diagnosed Metastatic Prostate Cancer
Noel Clarke
JAMA Oncology, 2021
View PDFchevron_right
Multitargeted Tyrosine Kinase Inhibition Produces Discordant Changes Between 99mTc-MDP Bone Scans and Other Disease Biomarkers: Analysis of a Phase II Study of Sunitinib for Metastatic Castration-Resistant Prostate Cancer
Anchisa Kunawudhi
Journal of Nuclear Medicine, 2012
View PDFchevron_right